Xu Z et al.SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts.Nat Commun 8:14570 (2017).
Becerikli M et al.Age-dependent alterations in osteoblast and osteoclast activity in human cancellous bone.J Cell Mol Med N/A:N/A (2017).
Huang H et al.Interleukin-6, tumor necrosis factor-alpha and receptor activator of nuclear factor kappa ligand are elevated in hypertrophic gastric mucosa of pachydermoperiostosis.Sci Rep 7:9686 (2017).
Melchiorre D et al.Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.Haematologica 101:219-25 (2016).
Takahashi N et al.Two-photon fluorescence lifetime imaging of primed SNARE complexes in presynaptic terminals and ß cells.Nat Commun 6:8531 (2015).
Tsushima H et al.CCAAT/enhancer-binding protein ß promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.Arthritis Res Ther 17:31 (2015).
Xue H et al.Low-intensity pulsed ultrasound accelerates tooth movement via activation of the BMP-2 signaling pathway.PLoS One 8:e68926 (2013).
Ibrahim T et al.Role of RANK, RANKL, OPG, and CXCR4 Tissue Markers in Predicting Bone Metastases in Breast Cancer Patients.Clin Breast Cancer : (2011).
Niida S et al.Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.J Biol Chem 279:5752-6 (2004).
Kikuchi T et al.Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors.J Immunol 166:3574-9 (2001).
Hsu H et al.Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.Proc Natl Acad Sci U S A 96:3540-5 (1999).